Lgm Pharma Company Profile
What is the competitive landscape for LGM PHARMA
LGM PHARMA has twelve approved drugs.
Summary for Lgm Pharma
| US Patents: | 0 |
| Tradenames: | 11 |
| Ingredients: | 11 |
| NDAs: | 12 |
Drugs and US Patents for Lgm Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lgm Pharma | URSODIOL | ursodiol | CAPSULE;ORAL | 205789-002 | May 8, 2020 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Lgm Pharma | BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE | acetaminophen; butalbital; caffeine; codeine phosphate | CAPSULE;ORAL | 076560-001 | Jun 10, 2004 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lgm Pharma | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | TABLET;ORAL | 209587-001 | Oct 31, 2018 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lgm Pharma | NABUMETONE | nabumetone | TABLET;ORAL | 203166-003 | Aug 30, 2019 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
